BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33000206)

  • 21. Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.
    Chen S; Ma P; Zhao Y; Li B; Jiang S; Xiong H; Wang Z; Wang H; Jin X; Liu C
    J Physiol Sci; 2017 Sep; 67(5):577-585. PubMed ID: 27655020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) Promotes Renal Cell Carcinoma Progression and Metastasis by Negatively Regulating miR-137.
    Zhao S; Wang Y; Luo M; Cui W; Zhou X; Miao L
    Med Sci Monit; 2018 Jun; 24():3824-3831. PubMed ID: 29874202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
    Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
    Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
    Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
    Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
    Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
    Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines.
    Eoh KJ; Paek J; Kim SW; Kim HJ; Lee HY; Lee SK; Kim YT
    Oncol Rep; 2017 Dec; 38(6):3481-3488. PubMed ID: 29039612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
    Liu S; Yang Y; Wang W; Pan X
    J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
    Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
    J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of ETS2 inhibits the invasion and metastasis of renal cell carcinoma cells by inducing EMT via the PI3K/Akt signaling pathway.
    Zhang GW; Tian X; Li Y; Wang ZQ; Li XD; Zhu CY
    Biomed Pharmacother; 2018 Aug; 104():119-126. PubMed ID: 29772431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
    Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
    PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway.
    Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X
    Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR‑133b affects cell proliferation, invasion and chemosensitivity in renal cell carcinoma by inhibiting the ERK signaling pathway.
    Xu Y; Ma Y; Liu XL; Gao SL
    Mol Med Rep; 2020 Jul; 22(1):67-76. PubMed ID: 32377748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma.
    Jin L; Fu H; Quan J; Pan X; He T; Hu J; Li Y; Li H; Yang Y; Ye J; Zhang F; Ni L; Yang S; Lai Y
    Mol Med Rep; 2017 Oct; 16(4):4463-4468. PubMed ID: 28765964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
    Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
    Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway.
    Park SA; Kim LK; Kim YT; Heo TH; Kim HJ
    Int J Biol Sci; 2020; 16(1):99-115. PubMed ID: 31892849
    [No Abstract]   [Full Text] [Related]  

  • 39. Highly Expressed Antisense Noncoding RNA in the INK4 Locus Promotes Growth and Invasion of Renal Clear Carcinoma Cells via the β-Catenin Pathway.
    Li Q; Tian Y; Hu G; Liang Y; Bai W; Li H
    Oncol Res; 2017 Sep; 25(8):1373-1382. PubMed ID: 28251886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. lncRNA ROR promotes the proliferation of renal cancer and is negatively associated with favorable prognosis.
    Shi J; Zhang W; Tian H; Zhang Q; Men T
    Mol Med Rep; 2017 Dec; 16(6):9561-9566. PubMed ID: 29039528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.